PMV Pharmaceuticals sets underwritten equity offering with TD Securities
PMV Pharmaceuticals entered an underwriting agreement with TD Securities for an underwritten offering of common stock, pre-funded warrants, and accompanying common stock warrants, expected to close Sep 02, 2026.